Cancer Research UK logo.
SearchDonate
  • Search

A study looking at SAR445514 for myeloma

Overview

Cancer types:

Blood cancers, Myeloma

Status:

Open

Phase:

Phase 1/2

Details

This study is looking at a drug called SAR445514 for myeloma and light chain amyloidosis.

It is open to people with myeloma and light chain amyloidosis that has come back after treatment or got worse during treatment.

Please note the study is only open to people with myeloma at the moment. We will update this summary when the study is open to people with light chain amyloidosis.

Recruitment start: 1 November 2023

Recruitment end: 11 September 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Emma Searle

Supported by

Sanofi

Last reviewed: 12 August 2024

CRUK internal database number: 19781

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.